Research Article
[Retracted] Comprehensive and Integrated Analysis Identifies ZEB1 as a Key Novel Gene in Oral Squamous Cell Carcinoma
Table 1
Correlation of ZEB1 expression with clinicopathological features in the GSE30784 dataset.
| Characteristic | Levels | ZEB1 expression | | Low (%) | High (%) |
| Age | ≤60 | 53 (23.2%) | 48 (21.1%) | 0.107 | >60 | 61 (26.8%) | 66 (28.9%) |
| Gender | Female | 59 (25.9%) | 46 (20.1%) | 0.230 | Male | 55 (24.1%) | 68 (29.8%) |
| Clinical T category | T3-T4 | 52 (22.8%) | 44 (19.3%) | 0.001 | T1-T2 | 56 (24.6%) | 60 (26.3%) |
| Clinical N category | N+ | 61 (26.8%) | 69 (30.3%) | 0.068 | N0 | 9 (3.9%) | 7 (3.1%) |
| Pathologic stage | High | 51 (22.4%) | 54 (22.6%) | 0.229 | Medium-low | 63 (27.6%) | 64 (27.4%) |
| TNM staging | I-II | 49 (20.5%) | 53 (23.2%) | 0.510 | III-IV | 69 (29.5%) | 61 (27.8%) |
|
|
Bold value implies < 0.05. |